This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Idogen Crecimiento futuro
Future controles de criterios 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Idogen.
Información clave
50.6%
Tasa de crecimiento de los beneficios
76.1%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Biotechs | 46.4% |
| Tasa de crecimiento de los ingresos | -122.1% |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Low |
| Última actualización | 10 May 2023 |
Actualizaciones recientes sobre el crecimiento futuro
No hay actualizaciones
Recent updates
Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2025 | N/A | -12 | -12 | -12 | 2 |
| 12/31/2024 | N/A | -12 | -11 | -12 | 2 |
| 12/31/2023 | N/A | -37 | -39 | -38 | 2 |
| 3/31/2023 | 1 | -44 | -42 | -40 | N/A |
| 12/31/2022 | 0 | -48 | -52 | -51 | N/A |
| 9/30/2022 | 3 | -50 | -55 | -53 | N/A |
| 6/30/2022 | 11 | -41 | -54 | -52 | N/A |
| 3/31/2022 | 12 | -39 | -48 | -48 | N/A |
| 12/31/2021 | 14 | -39 | -41 | -40 | N/A |
| 9/30/2021 | 13 | -33 | -36 | -36 | N/A |
| 6/30/2021 | 7 | -33 | -34 | -33 | N/A |
| 3/31/2021 | 8 | -31 | -37 | -36 | N/A |
| 12/31/2020 | 8 | -27 | -28 | -28 | N/A |
| 9/30/2020 | 7 | -27 | -25 | -25 | N/A |
| 6/30/2020 | 6 | -29 | -27 | -27 | N/A |
| 3/31/2020 | 5 | -32 | -25 | -25 | N/A |
| 12/31/2019 | 4 | -33 | -36 | -35 | N/A |
| 9/30/2019 | 7 | -29 | -29 | -28 | N/A |
| 6/30/2019 | 6 | -30 | -28 | -26 | N/A |
| 3/31/2019 | 5 | -27 | -30 | -27 | N/A |
| 12/31/2018 | 4 | -28 | -14 | -10 | N/A |
| 9/30/2018 | N/A | -30 | -24 | -18 | N/A |
| 6/30/2018 | N/A | -29 | -24 | -19 | N/A |
| 3/31/2018 | N/A | -25 | -18 | -12 | N/A |
| 12/31/2017 | N/A | -21 | -24 | -20 | N/A |
| 9/30/2017 | 0 | -18 | -17 | -15 | N/A |
| 6/30/2017 | 0 | -14 | -11 | -9 | N/A |
| 3/31/2017 | 0 | -13 | -12 | -12 | N/A |
| 12/31/2016 | 0 | -13 | N/A | -11 | N/A |
| 9/30/2016 | 0 | -12 | N/A | -12 | N/A |
| 6/30/2016 | 0 | -12 | N/A | -12 | N/A |
| 3/31/2016 | 0 | -10 | N/A | -10 | N/A |
| 12/31/2015 | 0 | -10 | N/A | -9 | N/A |
| 9/30/2015 | 0 | -8 | N/A | -8 | N/A |
| 6/30/2015 | 1 | -6 | N/A | -5 | N/A |
| 3/31/2015 | 0 | -4 | N/A | -3 | N/A |
| 12/31/2014 | 0 | -2 | N/A | -2 | N/A |
| 12/31/2013 | 0 | 0 | N/A | 0 | N/A |
| 12/31/2012 | 0 | 0 | N/A | N/A | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: IDOGEN is forecast to remain unprofitable over the next 3 years.
Beneficios vs. Mercado: IDOGEN is forecast to remain unprofitable over the next 3 years.
Beneficios de alto crecimiento: IDOGEN is forecast to remain unprofitable over the next 3 years.
Ingresos vs. Mercado: IDOGEN is forecast to have no revenue next year.
Ingresos de alto crecimiento: IDOGEN is forecast to have no revenue next year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if IDOGEN's Return on Equity is forecast to be high in 3 years time